Fig. 3From: Detection of disseminated tumor cells in bone marrow predict late recurrences in operable breast cancer patientsSurvival analyses according to disseminated tumor cell (DTC) detection in bone marrow (BM) samples obtained prior to surgery (a and b, n = 156) and 3 weeks and/or 6 months after surgery (c and d, n = 126) from operable breast cancer patients who did not experience disease recurrence or died during the first 5 years after surgery. Median follow-up was 15.3 years, but the first 5 years were subtracted from all survival times prior to analysisBack to article page